Your session is about to expire
← Back to Search
RhinAer Stylus for Chronic Rhinitis (RHINTRAC Trial)
RHINTRAC Trial Summary
This trial compares the RhinAer procedure, which uses RF energy, to a sham procedure for the treatment of chronic rhinitis.
RHINTRAC Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowRHINTRAC Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.RHINTRAC Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- Your nasal symptoms score is 6 or higher.I have a condition that causes me to bleed easily.I have a history of severe dry eye.I experience mild to severe nasal congestion.I am on blood thinners or high-dose aspirin that I can't stop before a procedure.I have had surgery for long-term nasal inflammation.I have moderate to severe runny nose symptoms.Your nasal symptoms score is 6 or higher.I am between 18 and 85 years old.I have had chronic rhinitis for over 6 months and am open to an office procedure.I have moderate to severe runny nose symptoms.I have had chronic rhinitis for over 6 months and am open to an office procedure.I am between 18 and 85 years old.I currently have a nasal or sinus infection.I have had chronic nosebleeds, severe nosebleeds in the last 3 months, medication-induced nasal congestion, or radiation therapy to my head or neck.My nose's structure changed due to past surgery or injury.I have a blockage that makes it hard to reach the back of my nose.I only have nasal allergy symptoms during certain seasons.I experience mild to severe nasal congestion.You have other medical conditions that could make it harder for your wounds to heal, increase the risk of surgery, or make it difficult to follow the study's rules.
- Group 1: RhinAer Treatment
- Group 2: Control Treatment
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is enrollment for this trial currently available to prospective participants?
"According to clinicaltrials.gov, this trial has ceased patient recruitment as of July 27th 2022 - its last date of editing. Despite the lack of available slots in this study, there are a number of other trials that have open positions at present time."
Could I qualify to join this research study?
"This clinical trial is accepting 120 voluntary participants between 18 and 85 years of age who experience signs of rhinitis. To be eligible for inclusion, the patient must willingly comply with any instructions specified in the study protocol as well as have nasal congestion ranging from mild to severe (rTNSS rating 1-3) and an overall rTNSS score ≥ 6."
Does this study include individuals aged 50 and above?
"This clinical trial has an upper age limit of 85 years and a lower one set at the legal age of consent."
How many sites within the city are offering this research experiment?
"This trial is being conducted across 20 locations, including Sacramento ENT (DaVinci Research) in Roseville and ENT of Georgia in Atlanta. Additionally, the Breathe Clear Institute in Torrance has also been enlisted as a clinical site for this study."
Who else is applying?
What state do they live in?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
What site did they apply to?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger